CSI Market
Sign In | Register

X4 Pharmaceuticals Inc (XFOR) Annual Balance Sheets

Annual · GAAP · USD millions
Access XFOR quarterly Balance Sheets →
The data below summarizes X4 Pharmaceuticals Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/XFOR/balance-sheets
https://api.csimarket.com/api/v1/companies/XFOR/fundamentals
https://api.csimarket.com/api/v1/companies/XFOR/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent217.05
Marketable Securities, Total MA35.95
Cash & Short-term Investments252.00
Accounts receivable0.57
Inventories4.48
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.53
Total Current Assets261.58
Equipment/Property/Plant Net0.18
Goodwill net17.35
Intangible Assets9.25
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent2.10
Research And Development Incentive Receivable-
Total Assets290.46
Liabilities
Accounts Payable, Current AC5.70
Accrued Liabilities, Current AC18.60
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current1.46
Taxes Payable0.00
Total Current Liabilities25.76
Long-term debt0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.98
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent77.44
Operating Lease Liability Current0.99
Operating Lease Liability Noncurrent-
Total Liabilities104.17
Stockholders' Equity
Common Stock Value0.09
Additional Paid In Capital Common Stock780.86
Retained Earnings / Accumulated Deficit-594.55
Accumulated Other Comprehensive Income0.00
Other Equity-0.11
Common Stockholder's Equity186.29
Total Stockholder's Equity186.29
Liabilities & Stockholder's Equity290.46
4 historic quarters locked

Sign in to unlock the full X4 Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About X4 Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001501697-26-000018

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI